Skip to main content

"Pharming is committed to bringing new therapies to people with rare diseases and will work closely with regulatory authorities across the globe in an effort to make this innovative option available to physicians who care for patients with APDS."

- Anurag Relan | Chief Medical Officer
Cookies: This website uses cookies Check the cookies page for more information Accept Decline